Abiopharma

New Autism Research to be Presented at European Purine Scientific Meeting

Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes

Kyivstar and Ukraine’s Securities Regulator Sign Memorandum to Advance Capital Markets Development and Expand Investment Access

Baker Hughes Announces Dates for Second-Quarter Earnings Release and Webcast

Fortrea Names Jason Knoblauch as Chief Financial Officer

Axsome Therapeutics Initiates FOCUS-3 Phase 3 Trial of Solriamfetol in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)

Can-Fite Secures Japanese Patent Allowance for Namodenosons Anti-Obesity Technology

OTC Markets Group Welcomes Nevada King Gold Corp. to OTCQX

Ermenegildo Zegna Group Reports Voting Results of the Annual General Meeting Held on June 26, 2026

Tilray Medical Expands Medical Cannabis Access for Veterans Through Lyphe Clinic at Aldershot’s Armed Forces Weekend